American Journal of Clinical Nutrition, Vol 67, 359-366, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease

WE Mitch
Renal Division, Emory University School of Medicine, Atlanta, GA 30322, USA. wmitch@emory.edu

Loss of lean body mass is common in patients with acute or chronic renal failure but the mechanisms causing this loss are only beginning to be understood. One mechanism involves an inability of uremic patients to activate the critical metabolic responses that maintain protein balance when dietary protein is limited. Metabolic responses to dietary protein restriction include a sharp reduction in the degradation of essential amino acids and protein; changes in protein synthesis are less reliable. If uremia prevents suppression of essential amino acid or protein degradation when dietary protein is reduced by anorexia, negative nitrogen balance and loss of lean body mass will ensue. One complication of uremia, metabolic acidosis, stimulates the degradation of branched-chain amino acids and proteins and therefore blocks the ability of the patient to respond to a low- protein diet. The mechanisms require glucocorticoids and involve increased activity of branched-chain keto acid dehydrogenase and the ubiquitin-proteasome proteolytic pathway; there also is increased transcription of genes encoding components of enzymes involved in the pathways. Besides acidosis, a low insulin concentration and cytokines activate the ubiquitin-proteasome proteolytic pathway. Understanding how proteolysis is activated, including how these genes are stimulated, is important because the same pathways are activated in diabetes, cancer, sepsis, burns, starvation, and muscle denervation. Activation of the ubiquitin-proteasome pathway leads to reduced lean body mass.

This article has been cited by other articles:

				N. J.M. Cano, D. Fouque, H. Roth, M. Aparicio, R. Azar, B. Canaud, P. Chauveau, C. Combe, M. Laville, X. M. Leverve, et al. Intradialytic Parenteral Nutrition Does Not Improve Survival in Malnourished Hemodialysis Patients: A 2-Year Multicenter, Prospective, Randomized Study J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2583 - 2591. [Abstract] [Full Text] [PDF]

				S. Basi, L. B. Pupim, E. M. Simmons, M. T. Sezer, Y. Shyr, S. Freedman, G. M. Chertow, R. L. Mehta, E. Paganini, J. Himmelfarb, et al. Insulin resistance in critically ill patients with acute renal failure Am J Physiol Renal Physiol, August 1, 2005; 289(2): F259 - F264. [Abstract] [Full Text] [PDF]

				R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF]

				D. R. Thomas The Relationship Between Functional Status and Inflammatory Disease in Older Adults J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M995 - 998. [Full Text] [PDF]

				W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1475 - 1484. [Abstract] [Full Text] [PDF]

				W. P. Pickering, F. E. Baker, J. Brown, H. L. Butler, S. Govindji, J. M. Parsons, I. Z. A. Pawluczyk, J. Walls, and A. Bevington Glucocorticoid antagonist RU38486 fails to block acid-induced muscle wasting in vivo or in vitro Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1475 - 1484. [Abstract] [Full Text]

				A. Battezzati, S. Benedini, A. Fattorini, M. Losa, P. Mortini, S. Bertoli, R. Lanzi, G. Testolin, G. Biolo, and L. Luzi Insulin action on protein metabolism in acromegalic patients Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E823 - E829. [Abstract] [Full Text] [PDF]

				A. Kato, M. Odamaki, T. Yamamoto, K. Yonemura, Y. Maruyama, H. Kumagai, and A. Hishida Influence of body composition on 5 year mortality in patients on regular haemodialysis Nephrol. Dial. Transplant., February 1, 2003; 18(2): 333 - 340. [Abstract] [Full Text] [PDF]

				R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, and Y. M. W. Janssen-Heininger Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways Am J Physiol Cell Physiol, September 1, 2002; 283(3): C714 - C721. [Abstract] [Full Text] [PDF]

				R. C. Morris Jr. and A. Sebastian Alkali Therapy In Renal Tubular Acidosis: Who Needs It? J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2186 - 2188. [Full Text] [PDF]

				G. Akner and T. Cederholm Treatment of protein-energy malnutrition in chronic nonmalignant disorders Am. J. Clinical Nutrition, July 1, 2001; 74(1): 6 - 24. [Abstract] [Full Text] [PDF]

				C. M. Avesani, L. Cuppari, A. C. Silva, D. M. Sigulem, M. Cendoroglo, R. Sesso, and S. A. Draibe Resting energy expenditure in pre-dialysis diabetic patients Nephrol. Dial. Transplant., March 1, 2001; 16(3): 556 - 565. [Abstract] [Full Text] [PDF]

				D. P. Kotler Cachexia Ann Intern Med, October 17, 2000; 133(8): 622 - 634. [Abstract] [Full Text] [PDF]

				J. D. Stookey Protein intake and appendicular skeletal muscle mass in older men Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1209 - 1209. [Full Text] [PDF]

				N. Szewczyk, J. Hartman, S. Barmada, and L. Jacobson Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans J. Cell Sci., January 6, 2000; 113(11): 2003 - 2010. [Abstract] [PDF]